Evaluation of a Non-cross-linked Hyaluronic Acid Medical Device ("Electri" and "XELA REDERM") for Improving Facial Skin Appearance

Exclusion Criteria

• •Infection or inflammation in the implant injection site.
• •Pregnancy, lactation.
• •Subject's intention to undergo procedures involving chemical peels, laser irradiation, botulinum toxin injection or other similar procedures in the injection site within the next 45 days after inclusion in the post-marketing investigation.
• •Subject underwent procedures involving chemical peels, laser irradiation, botulinum toxin injection or other similar procedures in the injection site within 35 days prior to inclusion in the post-marketing investigation.
• •Chronic or acute severe or decompensated visceral diseases.
• •Known hypersensitivity to hyaluronic acid, its metabolites, or to the excipients of the injectable implant.
• •Known hypersensitivity to analgesics.
• •Subject took significant doses of vitamin E, NSAIDs or anticoagulants during the last 7 days.
• •Refusal or suspected inability of the subject to comply with the requirements of the CIP.
• •Subject has difficulty in understanding the language in which the informed consent is written.
• •Any other reason that, in the opinion of the investigator, prevents the subject from participating in the post-marketing investigation.
• •Subject takes participation in other clinical investigation.